<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>60(1)</volume><submitter>Yang YF</submitter><funding>National Natural Science Foundation of China</funding><pubmed_abstract>&lt;h4>Context&lt;/h4>Yi-Qi Cong-Ming (YQCM) decoction has been widely used to prevent age-related hearing loss (ARHL), the most prevalent neurodegenerative disease in the elderly.&lt;h4>Objective&lt;/h4>To explore the mechanism of YQCM decoction in the treatment of ARHL.&lt;h4>Materials and methods&lt;/h4>The chemical constituents of YQCM were screened from the Traditional Chinese Medicine Systems Pharmacology Database. Potential targets of YQCM against ARHL were predicted by DrugBank, GeneCards, and OMIM database. Protein-protein network and enrichment analysis were used for exploring possible molecular mechanisms. Molecular docking and an &lt;i>in vitro&lt;/i> model of ARHL by exposing auditory cells with 100 μM H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub> for 3 h were applied. Cell viability and mitochondrial membrane potentia</pubmed_abstract><journal>Pharmaceutical biology</journal><pagination>1478-1490</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9359200</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Network pharmacology and experimental evidence reveal the protective mechanism of Yi-Qi Cong-Ming decoction on age-related hearing loss.</pubmed_title><pmcid>PMC9359200</pmcid><pubmed_authors>Yang YF</pubmed_authors><pubmed_authors>Dong Y</pubmed_authors><pubmed_authors>Wu RX</pubmed_authors><pubmed_authors>Shi JR</pubmed_authors><pubmed_authors>Liu Q</pubmed_authors><pubmed_authors>Yan XR</pubmed_authors><pubmed_authors>Chu M</pubmed_authors><pubmed_authors>Fu SP</pubmed_authors><pubmed_authors>Li N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Network pharmacology and experimental evidence reveal the protective mechanism of Yi-Qi Cong-Ming decoction on age-related hearing loss.</name><description>&lt;h4>Context&lt;/h4>Yi-Qi Cong-Ming (YQCM) decoction has been widely used to prevent age-related hearing loss (ARHL), the most prevalent neurodegenerative disease in the elderly.&lt;h4>Objective&lt;/h4>To explore the mechanism of YQCM decoction in the treatment of ARHL.&lt;h4>Materials and methods&lt;/h4>The chemical constituents of YQCM were screened from the Traditional Chinese Medicine Systems Pharmacology Database. Potential targets of YQCM against ARHL were predicted by DrugBank, GeneCards, and OMIM database. Protein-protein network and enrichment analysis were used for exploring possible molecular mechanisms. Molecular docking and an &lt;i>in vitro&lt;/i> model of ARHL by exposing auditory cells with 100 μM H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub> for 3 h were applied. Cell viability and mitochondrial membrane potentia</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-19T12:10:45.184Z</modification><creation>2025-04-19T12:10:45.184Z</creation></dates><accession>S-EPMC9359200</accession><cross_references><pubmed>35938504</pubmed><doi>10.1080/13880209.2022.2101671</doi></cross_references></HashMap>